403 related articles for article (PubMed ID: 3352595)
1. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930.
Neijt HC; Karpf A; Schoeffter P; Engel G; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):493-9. PubMed ID: 3412489
[TBL] [Abstract][Full Text] [Related]
3. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
4. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
5. Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.
Hoyer D; Neijt HC; Karpf A
J Recept Res; 1989; 9(1):65-79. PubMed ID: 2915346
[TBL] [Abstract][Full Text] [Related]
6. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
8. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
Morain P; Abraham C; Portevin B; De Nanteuil G
Mol Pharmacol; 1994 Oct; 46(4):732-42. PubMed ID: 7969053
[TBL] [Abstract][Full Text] [Related]
9. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
10. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
O'Hara N; Yokota S; Kouchi Y; Ono H
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
[TBL] [Abstract][Full Text] [Related]
14. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
Sills MA; Wolfe BB; Frazer A
Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
[TBL] [Abstract][Full Text] [Related]
15. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
[TBL] [Abstract][Full Text] [Related]
16. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
17. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
Pranzatelli MR; Murthy JN; Pluchino RS
J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
Unsworth CD; Molinoff PB
J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.
Bönisch H; Barann M; Graupner J; Göthert M
Br J Pharmacol; 1993 Feb; 108(2):436-42. PubMed ID: 7680594
[TBL] [Abstract][Full Text] [Related]
20. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
Kilpatrick GJ; Jones BJ; Tyers MB
Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
